Status:
ENROLLING_BY_INVITATION
Stop Ovarian Cancer Young; Effect of the Opportunistic Salpingectomy on Age of Menopause
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Catharina Ziekenhuis Eindhoven
Conditions:
Salpingectomy
Tubal Ligation
Eligibility:
FEMALE
30-45 years
Brief Summary
The aim of this study is to evaluate the long-term safety of on the onset of menopause.
Detailed Description
The aim of this study is to evaluate the long-term safety of on the onset of menopause. To investigate the effect of Opportunistic Salpingectomy on the age of menopause, we will compare age of menopau...
Eligibility Criteria
Inclusion
- Intervention group
- Undergoing an Opportunistic Salpingectomy as sterilization method
- Premenopausal status at enrolment
- Age between 30 and 45 years
- Will have residual ovarian tissue after surgery
- Able to understand the written or spoken Dutch language
- Gives consent for participating in surveys
- Control group
- Premenopausal status at enrolment
- Either sterilization by tubal ligation or no sterilization at all
- Age between 35 and 45 years
- Able to understand the written or spoken Dutch language
- Gives consent for participating in surveys
Exclusion
- Postmenopausal status at enrolment
- Under the age of 35 or above 45
- Previous salpingectomy of oophorectomy
- Previous hysterectomy
- Women with abnormal karyotype (such as Turner Syndrome and Fragile X syndrome)
- Underwent chemotherapy or radiation
- Unable to understand the written or spoken Dutch language
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2036
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04757922
Start Date
March 1 2021
End Date
January 1 2036
Last Update
January 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catharina Ziekenhuis
Eindhoven, Netherlands, 5623 EJ